New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
08:05 EDTKERXKeryx announces marketing approval of ferric citrate in Japan
Keryx announced that its Japanese partner, Japan Tobacco has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Under the license agreement with JT and Torii, within 30 days, Keryx will receive a non-refundable payment of $10M for the achievement of the marketing approval milestone. Keryx will also receive double-digit tiered royalties on net sales of Riona in Japan, as well as up to an additional $55M upon the achievement of certain annual net sales milestones.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
08:08 EDTKERXKeryx appoints John Neylan, MD, as Chief Medical Officer
Keryx Biopharmaceuticals announced the appointment of John Neylan, MD to the newly created position of Chief Medical Officer. In this role, Dr. Neylan will be responsible for oversight of medical affairs, clinical development and pharmacovigilence at Keryx. Dr. Neylan comes to Keryx from Genzyme, where since 2008 he served in the capacity of SVP, Clinical Development, focusing on specialty metabolic diseases.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use